Qube Research & Technologies (QRT)
REGN icon

Qube Research & Technologies (QRT)’s Regeneron Pharmaceuticals REGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.49M Sell
8,400
-20,600
-71% -$15.8M 0.01% 1530
2025
Q4 		$22.4M Sell
29,000
-14,900
-34% -$10.1M 0.02% 848
2025
Q3 		$24.7M Buy
43,900
+4,200
+11% +$2.37M 0.03% 796
2025
Q2 		$20.8M Buy
39,700
+31,800
+403% +$17.7M 0.02% 855
2025
Q1 		$5.01M Buy
7,900
+5,400
+216% +$3.71M 0.01% 1523
2024
Q4 		$1.78M Buy
+2,500
New +$2.1M ﹤0.01% 1927
2024
Q2 		– Sell
-2,600
Closed -$2.5M – 4564
2024
Q1 		$2.5M Buy
+2,600
New +$2.47M ﹤0.01% 1626

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s REGN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Regeneron Pharmaceuticals (REGN) stake by 41% in Q1 2026, selling an estimated $45M and leaving 83,358 shares worth $64.4M. The position accounts for 0.07% of the portfolio, ranked #337.

Qube Research & Technologies (QRT) first reported a position in REGN in Q3 2018 and has held it in 22 quarters since. The position peaked at $446M in Q1 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Qube Research & Technologies (QRT) held 83,358 shares of Regeneron Pharmaceuticals worth $64.4M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 58,825 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $45M.
  • Regeneron Pharmaceuticals made up 0.07% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #337 holding.
  • Qube Research & Technologies (QRT) first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 22 quarters since.
  • Qube Research & Technologies (QRT)'s Regeneron Pharmaceuticals position peaked at $446M in Q1 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.